Table 3

EULAR good response: univariate and multivariate logistic regression analyses

VariableCoefficientOR (95% CI)p Value
Univariate adjusted analyses*
 Previous synthetic DMARDs−0.170.84 (0.75 to 0.94)0.002
 Previous biological DMARDs 0–1 (vs ≥2)0.551.73 (1.25 to 2.38)0.001
 HAQ at baseline0.181.20 (0.80 to 1.70)0.30
 Disease duration−0.010.99 (0.98 to 1.01)0.48
 Rheumatoid factor positive (vs negative)0.441.50 (1.01 to 2.36)0.04
 DAS28 at baseline−0.080.90 (0.87 to 1.02)0.11
 Concomitant synthetic DMARD yes (vs no)−0.050.95 (0.67 to 1.33)0.75
 Concomitant glucocorticoids yes (vs no)0.260.77 (0.57 to 1.04)0.09
 Anti-CCP positive (vs negative)1.093.00 (1.56 to 5.77)0.001
Multivariate adjusted analysis*
 Anti-CCP positive (vs negative)1.052.86 (1.43 to 5.71)0.003
 Previous biological DMARDS 0–1 (vs ≥2)0.641.89 (1.02 to 3.51)0.04
 DAS28 at baseline−0.290.74 (0.61 to 0.91)0.003
 Previous synthetic DMARDs−0.180.84 (0.7 to 1.01)0.06
  • * Adjusted for age and sex.

  • anti-CCP, anti-cyclic citrullinated peptide antibodies; DAS28, 28-joint count Disease Activity Score; DMARDs, disease-modifying antirheumatic drugs; EULAR, European League Against Rheumatism; HAQ, Health Assessment Questionnaire.